Axiom Health Appoints Russell Lewis as CEO and Jim Best as CCO to Drive Market Growth and Deliver Increased Value to Clients

On March 28, 2024, Axiom Health appointed Russell “Rusty” Lewis as Chief Executive Officer (CEO) and Jim Best as Chief Commercial Officer (CCO). These appointments were made to strengthen the company’s leadership capabilities and support its efforts to expand its market presence and deliver increased value to clients.

Russell Lewis has over 20 years of experience in the healthcare industry and will bring valuable insights to his role as CEO. He has held key positions in organizations like McKesson, Amerisource Bergen, and Vizient, where he focused on driving innovation in healthcare technology. His expertise will be crucial in guiding Axiom Health’s growth trajectory.

Jim Best, who joins Axiom Health with over 20 years of experience in the healthcare industry, was named CCO. He has held sales and marketing leadership positions at companies like Stryker, Integra Lifesciences, TriMed, and Komodo Health. His deep understanding of the challenges faced by medical device sales and marketing teams will be valuable in enhancing client success initiatives at Axiom Health.

The company is excited about these new appointments and believes that they align with its strategic vision for delivering exceptional value in the medical device market. The leadership additions are expected to support the company’s commitment to empowering sales and marketing teams with data-driven insights that drive informed decision-making and lead to better outcomes.

For more information about these appointments or any other queries related to Axiom Health please contact their Media Relations Department at [email protected] or visit their website at www.axiomhealth.com